BPG is committed to discovery and dissemination of knowledge
Articles in Press
8/19/2025 3:31:36 AM | Browse: 8 | Download: 0
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Minireviews |
Article Title |
Explainable artificial intelligence for personalized management of inflammatory bowel disease: A minireview of recent advances
|
Manuscript Source |
Invited Manuscript |
All Author List |
Uchenna E Okpete and Haewon Byeon |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Research Foundation of Korea |
RS-2023-00237287 |
|
Corresponding Author |
Haewon Byeon, Associate Professor, Director, PhD, Worker’s Care and Digital Health Lab, Department of Future Technology, Korea University of Technology and Education, 1600, Chungjeol-ro, Cheonan 31253, South Korea. bhwpuma@naver.com |
Key Words |
Precision medicine; Ulcerative colitis; Crohn’s disease; Heterogeneous population; Machine learning; Interpretability; Feature attribution; Clinical decision-making |
Core Tip |
Personalized management of inflammatory bowel disease is essential because of its heterogeneous clinical presentations and variable treatment responses. While artificial intelligence (AI) offers powerful tools for analyzing patient data and guiding treatment, many AI models lack transparency, which limits their clinical adoption. Explainable AI addresses this issue by making AI predictions more interpretable and trustworthy. This minireview highlights recent advancements in the application of explainable AI to inflammatory bowel disease management, including its use in predicting disease progression, selecting therapies, and monitoring treatment response. |
Citation |
Okpete UE, Byeon H. Explainable artificial intelligence for personalized management of inflammatory bowel disease: A minireview of recent advances. World J Gastroenterol 2025; In press |
 |
Received |
|
2025-06-23 13:15 |
 |
Peer-Review Started |
|
2025-06-23 13:15 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-07-10 09:20 |
 |
Revised |
|
2025-07-21 16:14 |
 |
Second Decision |
|
2025-08-19 02:43 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-08-19 03:31 |
 |
Articles in Press |
|
2025-08-19 03:31 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345